June 04, 2025 — HeartSciences Inc. has announced that the U.S. Food and Drug Administration has granted Breakthrough ...
June 12, 2025 — Viz.ai recently announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for ...
June 12, 2025 – The American Society of Echocardiography (ASE) and Cardiovascular Research Foundation (CRF) have ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
June 12, 2025 — GE HealthCare has announced the combination of GE HealthCare’s proprietary features and algorithms with ...
June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...

As healthcare systems continue to shift toward value-based care and proactive disease management, remote monitoring has ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
June 6, 2025 – A large retrospective review of more than 100,000 patients found the use of glucagon-like peptide-1 ...
June 5, 2025 – Penumbra, Inc. has announced the U.S. Food and Drug Administration (FDA) clearance and launch of the Ruby ...
June 4, 2025 — A new study published in The Annals of Thoracic Surgery, a journal from The Society of Thoracic Surgeons ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
June 3, 2025 — Bayer announced it will present multiple new analyses of the Kerendia (finerenone) clinical trial program ...
May 30, 2025 — BiVACOR, a clinical-stage medical device company developing the world’s first titanium Total Artificial ...
May 28, 2025 — Siemens Healthineers has introduced the first mobile stroke unit (MSU) featuring the Somatom On.site head ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
May 27, 2025 — Abbott has announced the U.S. Food and Drug Administration (FDA) has approved the company's Tendyne ...
May 27, 2025 — CeleCor Therapeutics has completed its multinational Phase 3 clinical trial of DisaggproT (zalunfiban) ...
May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...